# Pramipexole to Target "Anhedonic Depression"

> **NCT04121091** · PHASE2 · COMPLETED · sponsor: **Region Skane** · enrollment: 13 (actual)

## Conditions studied

- Depression, Bipolar
- Depression, Unipolar
- Dysthymia
- Anhedonia

## Interventions

- **DRUG:** Pramipexole Pill

## Key facts

- **NCT ID:** NCT04121091
- **Lead sponsor:** Region Skane
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-04
- **Primary completion:** 2021-03-18
- **Final completion:** 2021-03-18
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2025-12-12

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04121091

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04121091, "Pramipexole to Target "Anhedonic Depression"". Retrieved via AI Analytics 2026-06-26 from https://api.ai-analytics.org/clinical/NCT04121091. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*